Noveris Health Sciences Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MYCOF research report →
Companywww.mydecine.com
Noveris Health Sciences Inc. is a biotechnology company, which engages in the research, drug development, and clinical trials of psilocybin products. The company was founded by Parente Carman, Damon Michaels, and Robert Roscow on September 27, 2013 and is headquartered in Vancouver, Canada.
- CEO
- Jason Birmingham
- IPO
- 2021
- Employees
- 3
- HQ
- Vancouver, BC, CA
Price Chart
Valuation
- Market Cap
- $63.23M
- P/E
- 9.80
- P/S
- 0.00
- P/B
- -1.42
- EV/EBITDA
- 13.99
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -14.60%
- ROIC
- 47.11%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $2.92M · 192.67%
- EPS
- $2.37 · 4580.15%
- Op Income
- $-549,937
- FCF YoY
- 0.00%
Performance & Tape
- 52W High
- $1.40
- 52W Low
- $0.03
- 50D MA
- $1.09
- 200D MA
- $0.41
- Beta
- 0.57
- Avg Volume
- 544
Get TickerSpark's AI analysis on MYCOF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our MYCOF Coverage
We haven't published any research on MYCOF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate MYCOF Report →